- Exchange: New York
- Sector: Consumer, Non-cyclical
- Industry: Pharmaceuticals
- Sub-Industry: Medical-Drugs
Snapshot for Elan Corp PLC (ELN)
| Open: | 13.2700 | Day's Range: | 13.2200 - 14.4900 | Volume: | 8,535,627 | Bid: | 14.2900 |
|---|---|---|---|---|---|---|---|
| Previous Close: | 13.1900 | 52wk Range: | 8.5800 - 15.2700 | 1-Yr Rtn: | +52.29% | Ask: | 14.3000 |
Key Statistics for ELN
| Current P/E Ratio (ttm) | 115.6556 |
|---|---|
| Estimated P/E (12/2012) | 1,588.8889 |
| Earnings Per Share (USD) (ttm) | 0.1236 |
| Est. EPS (USD) (12/2012) | 0.0090 |
| Est. PEG Ratio | - |
| Market Cap (M USD) | 8,460.46 |
| Shares Outstanding (M) | 591.64 |
| Enterprise Value (M EUR) (ttm) | 8,274.76 |
| Enterprise Value/EBITDA (ttm) | - |
| Price/Book (mrq) | 10.4534 |
| Price/Sale (ttm) | 6.1520 |
| Dividend Indicated Gross Yield | 0.0000 |
| Next Earnings Announcement | 07/27/2012 |
More ELN Key Statistics
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Financials for ELN
- Operating
- Investing
- Financing (M/EUR)
Company Profile & Key Executives for ELN
Elan Corporation plc is a specialty pharmaceutical company. The Group's drug delivery technologies are designed to aid and control the absorption and utilization of active pharmaceutical compounds. Elan's Pharmaceutical division focuses on the discovery, development and commercialization of products in the areas of acute care, pain management, infectious diseases and neurology.
| Robert Alexander Ingram "Bob"Chairman | G Kelly MartinChief Executive Officer |
| Fabiana Lacerca-AllenChief Compliance Officer | Nigel ClerkinExec VP/CFO |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Links
Top Forex Trading Resources
Advertisement
Advertisement
Advertisements
Rate this Page